North Star Investment Management’s Greenwich LifeSciences GLSI Stock Holding History

North Star Investment Management’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.23K	Hold	51	–	–	﹤0.01%	1462
2025 Q4	$1.07K	Hold	51	–	–	﹤0.01%	1386
2025 Q3	$507	Hold	51	–	–	﹤0.01%	1241
2025 Q2	$463	Hold	51	–	–	﹤0.01%	1163
2025 Q1	$487	Hold	51	–	–	﹤0.01%	1145
2024 Q4	$573	Hold	51	–	–	﹤0.01%	1167
2024 Q3	$733	Hold	51	–	–	﹤0.01%	1128
2024 Q2	$880	Hold	51	–	–	﹤0.01%	1101
2024 Q1	$1.02K	Hold	51	–	–	﹤0.01%	1155
2023 Q4	$537	Hold	51	–	–	﹤0.01%	1134
2023 Q3	$451	Hold	51	–	–	﹤0.01%	1208
2023 Q2	$492	Hold	51	–	–	﹤0.01%	1216
2023 Q1	$703	Hold	51	–	–	﹤0.01%	1206
2022 Q4	$775	Hold	51	–	–	﹤0.01%	1195
2022 Q3	$0	Hold	51	–	–	﹤0.01%	1148
2022 Q2	$0	Hold	51	–	–	﹤0.01%	1151
2022 Q1	$1K	Hold	51	–	–	﹤0.01%	1101
2021 Q4	$1K	Hold	51	–	–	﹤0.01%	1129
2021 Q3	$2K	Hold	51	–	–	﹤0.01%	1035
2021 Q2	$2K	Hold	51	–	–	﹤0.01%	1017
2021 Q1	$2K	Buy	+51	New	+$1.74K	﹤0.01%	973

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

North Star Investment Management's GLSI Position: Q1 2026 in Review

North Star Investment Management held its Greenwich LifeSciences (GLSI) position steady in Q1 2026 at 51 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

North Star Investment Management first reported a position in GLSI in Q1 2021 and has held it in 21 quarters since. The position peaked at $2K in Q3 2021. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

North Star Investment Management held 51 shares of Greenwich LifeSciences worth $1.23K as of Q1 2026.
North Star Investment Management left its Greenwich LifeSciences share count unchanged in Q1 2026.
Greenwich LifeSciences made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1462 holding.
North Star Investment Management first reported a position in Greenwich LifeSciences in Q1 2021 and has held it in 21 quarters since.
North Star Investment Management's Greenwich LifeSciences position peaked at $2K in Q3 2021.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.